Patrice Ravel Selected Research

Lung Neoplasms (Lung Cancer)

5/2012

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrice Ravel Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 01/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 11/2010
2	Malaria 01/2023 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2008
2	Melanoma (Melanoma, Malignant) 12/2018 - 04/2010
2	Dystonia (Limb Dystonia) 02/2010 - 04/2004
1	Parasitic Diseases (Parasitic Disease) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Rheumatoid Arthritis 07/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2013
1	Lung Neoplasms (Lung Cancer) 05/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2012
1	Hematologic Neoplasms (Hematological Malignancy) 11/2011
1	Kidney Neoplasms (Kidney Cancer) 11/2010
1	Disease Progression 02/2010
1	Dystonia musculorum deformans type 1 02/2010
1	Brain Neoplasms (Brain Tumor) 01/2004

Drug/Important Bio-Agent (IBA)

3	Cancer VaccinesIBA 12/2018 - 11/2011
2	VaccinesIBA 01/2023 - 11/2011
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2021
2	Sunitinib (Sutent)FDA Link 12/2021 - 11/2010
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2013
2	Peptides (Polypeptides)IBA 12/2018 - 05/2012
2	AntigensIBA 12/2018 - 11/2011
2	temsirolimus FDA Link 12/2018 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2012 - 04/2010
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	GPI-Linked ProteinsIBA 01/2023
1	AntibodiesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	pazopanib FDA Link 12/2021
1	Angiogenesis InhibitorsIBA 12/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Hormones (Hormone)IBA 01/2021
1	InterferonsIBA 01/2021
1	PlatinumIBA 01/2021
1	CytokinesIBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Shiga Toxin (Shigella Toxin)IBA 12/2018
1	liquid crystal polymerIBA 01/2017
1	artemisinin (artemisinine)IBA 01/2016
1	Everolimus FDA Link 01/2016
1	MTOR InhibitorsIBA 01/2016
1	Tumor Necrosis Factor InhibitorsIBA 07/2014
1	HLA-DR Antigens (HLA-DR)IBA 05/2012
1	EpitopesIBA 05/2012
1	AutoantigensIBA 11/2011
1	HLA-A*02:01 antigenIBA 04/2010
1	Tamoxifen FDA LinkGeneric 01/2008
1	Estrogen Receptor alphaIBA 01/2008
1	Complementary DNA (cDNA)IBA 01/2008
1	Estrogen ReceptorsIBA 01/2008
1	ThalliumIBA 01/2004

Therapy/Procedure

4	Immunotherapy 11/2022 - 04/2010
4	Therapeutics 01/2021 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2021 - 05/2012
2	Deep Brain Stimulation 02/2010 - 04/2004
1	Chemoradiotherapy 01/2021
1	Radiotherapy 01/2021